Mallok Akel, Vaillant Jaqueline Dranguet, Soto María Teresa Díaz, Viebahn-Hänsler Renate, Viart María de Los Angeles Béquer, Pérez Angela Fraga, Cedeño Rubens Iván Donoso, Fernández Olga Sonia León
Neurol Res. 2015 Mar;37(3):204-10. doi: 10.1179/1743132814Y.0000000445. Epub 2014 Sep 25.
Epilepsy is a common seizure disorder affecting approximately 70 million people worldwide. Mitochondrial dysfunction and antioxidant/prooxidant imbalance are emerging as factors that contribute to epileptogenesis. As medical ozone was able to reestablish cellular redox balance and to maintain the protective effects mediated by A1 receptors (A1Rs), the aim of this work was to study ozone's effects on antioxidant/prooxidant balance and to clarify if A1Rs play a role in ozone's protective actions against pentylenetetrazole (PTZ)-induced convulsions in mice.
Influence of ozone's treatments in mice submitted to PTZ-induced seizures was studied. Ozone was administered by rectal insufflation 1 mg/kg (5, 10, 15, 20 treatments), one per day, of 1-1·5 ml at an ozone concentration of 20 μg/ml. Mice received PTZ (90 mg/kg i.p.) 24 hours after the last ozone treatment. Oxygen control groups 26 mg/kg were introduced. Latency to first seizure was determined. Antioxidant/prooxidant balance in brain homogenates was studied. A1 adenosine receptors' effects on ozone's protective actions against seizures were evaluated using 8-cyclopentyl-1,3-dipropylxanthine (DPCPX).
Highest latency was observed when mice received 15 ozone treatments. Oxygen + PTZ group did not achieve protection against neither convulsions nor brain oxidative injury. Fifteen treatments of ozone protected against biomolecules oxidative damage and the antioxidant systems as well. 8-Cyclopentyl-1,3-dipropylxanthine abolished the ozone's protection.
Ozone therapy increased the latency for the first seizure and the survival percentage. These effects are discussed in point of ozone's capacity to reestablish cellular redox balance, decrease biomolecules damage, and regulate activation of A1 adenosine receptors in PTZ-induced seizures.
癫痫是一种常见的发作性疾病,全球约有7000万人受其影响。线粒体功能障碍以及抗氧化剂/促氧化剂失衡正逐渐成为导致癫痫发生的因素。由于医用臭氧能够重建细胞氧化还原平衡并维持由A1受体(A1Rs)介导的保护作用,本研究旨在探讨臭氧对抗氧化剂/促氧化剂平衡的影响,并阐明A1Rs在臭氧对戊四氮(PTZ)诱导的小鼠惊厥的保护作用中是否发挥作用。
研究了臭氧处理对PTZ诱导惊厥的小鼠的影响。通过直肠注入给予臭氧,剂量为1 mg/kg(5、10、15、20次处理),每天1次,注入1 - 1.5 ml,臭氧浓度为20 μg/ml。在最后一次臭氧处理24小时后,小鼠接受PTZ(90 mg/kg腹腔注射)。引入了26 mg/kg的氧气对照组。测定首次发作的潜伏期。研究脑匀浆中的抗氧化剂/促氧化剂平衡。使用8-环戊基-1,3-二丙基黄嘌呤(DPCPX)评估A1腺苷受体对臭氧抗惊厥保护作用的影响。
当小鼠接受15次臭氧处理时,观察到最长的潜伏期。氧气 + PTZ组对惊厥和脑氧化损伤均未起到保护作用。15次臭氧处理可保护生物分子免受氧化损伤以及抗氧化系统。8-环戊基-1,3-二丙基黄嘌呤消除了臭氧的保护作用。
臭氧疗法增加了首次发作的潜伏期和存活率。从臭氧重建细胞氧化还原平衡、减少生物分子损伤以及调节PTZ诱导惊厥中A1腺苷受体激活的能力方面对这些作用进行了讨论。